Stanford researchers develop a new flu vaccine method that targets genetic differences to boost broader immunity.
Stanford Medicine researchers have developed a new method to enhance seasonal flu vaccine effectiveness by addressing individual genetic differences that affect immune responses. Current vaccines often lead to a bias towards certain flu subtypes, but the new approach, tested in human and animal models, couples antigens from multiple strains to boost immunity against a wider range of flu types, including potential pandemic strains. This could significantly improve vaccine efficacy.
3 months ago
6 Articles
Further Reading
You have 4 free stories remaining this month. Subscribe anytime for unlimited access.